Table 5 Performance of the studied non-invasive markers in the detection of early (F1–F2) in the studied group
Cutoff value | Sens% | Spec% | PPV% | NPV% | AUC | 95% CI | |
|---|---|---|---|---|---|---|---|
APRI | > 0.96 | 46.4% | 91.9% | 94.7% | 32.2% | 0.745 | 0.71–0.82 |
M-APRI | >0.16 | 61.3% | 96.5% | 97.9% | 40.4% | 0.831 | 0.63–0.88 |
FIB-4 | >0.019 | 54.8% | 94.5% | 97.7% | 36.9% | 0.750 | 0.55–0.85 |
M-FIB-4 | >0.005 | 49.7% | 96.5% | 97.4% | 34.4% | 0.759 | 0.64–0.79 |
B-AST | >−8 | 74.2% | 75.7% | 90.5% | 43.2% | 0.758 | 0.66–0.85 |